Royal Caribbean Cruises Ltd. · RCL · FY2026 Q3 · Calendar Q4 2026
Royal Caribbean raises outlook as bookings stay strong
Management presented sustained travel demand and a broader vacation platform as the main supports for continued growth. The outlook improved, but execution on the Sandals and Beaches transaction and future capacity remain key tests.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about RCL FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Following Q3 performance, management increased full-year adjusted EPS guidance to $17.85-$17.95. The company also announced a $3 billion purchase of a 50% equity stake in Sandals and Beaches Resorts, with closing expected in early 2027.
Guidance delta
Full-year adjusted EPS guidance was raised to $17.85-$17.95.
Key takeaways
- Booking demand accelerated, with record-high 2026 and 2027 book positions and reservations growing at a mid-teens year-over-year rate.
- The Sandals and Beaches transaction broadens the company into all-inclusive resorts and is expected by management to be immediately earnings-accretive.
- New ship deployments, Celebrity River Cruises and loyalty and technology initiatives support the stated growth strategy.
- Management cited $7.4 billion of liquidity and leverage below 3x as financial support for growth and shareholder returns.
Management priorities
- Close and integrate the Sandals and Beaches transaction in early 2027.
- Expand cruise, river-cruise and all-inclusive resort offerings, including new ship deployments and resort development.
- Continue investing in loyalty, technology and AI-driven revenue management.
Follow RCL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 20, 2026 |
| Susquehanna | Positive | Positive | Maintain | Oct 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Jefferies | Buy | Hold | Upgrade | Oct 8, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Sep 28, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Sep 28, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 24, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 24, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 23, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 29, 2026 |
| UBS | Buy | Buy | Maintain | May 14, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 2, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jan 22, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jan 12, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 2, 2025 |
| Loop Capital | Buy | Buy | Maintain | Jun 3, 2025 |
| Macquarie | Outperform | Outperform | Maintain | May 9, 2025 |
| Argus Research | Buy | Buy | Maintain | Jan 29, 2025 |
| Credit Suisse | Outperform | Outperform | Maintain | May 5, 2023 |
| Berenberg | Hold | Sell | Upgrade | Dec 10, 2021 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jun 16, 2021 |
| Redburn Partners | Neutral | Buy | Downgrade | Jun 22, 2020 |
| Redburn | Neutral | Buy | Downgrade | Jun 22, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 20, 2020 |
| Nomura | Buy | Buy | Maintain | Apr 8, 2020 |
| CFRA | Sell | Buy | Downgrade | Feb 10, 2020 |
| Buckingham Research | Neutral | Buy | Downgrade | Feb 3, 2020 |
| Buckingham | Neutral | Buy | Downgrade | Feb 3, 2020 |
| Argus | Hold | Buy | Downgrade | Aug 13, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 26, 2019 |
| Wedbush | Outperform | Outperform | Maintain | May 2, 2019 |
| Bank of America | Neutral | Neutral | Maintain | Sep 26, 2018 |
| SpareBank 1 Markets | Sell | Neutral | Downgrade | Jun 10, 2015 |
| Sparebank | Sell | Neutral | Downgrade | Jun 10, 2015 |
| Danske Bank | Hold | Sell | Upgrade | May 6, 2015 |
| Carnegie | Hold | Sell | Upgrade | Apr 23, 2015 |
| Pareto Securities | Sell | Hold | Downgrade | Mar 25, 2015 |
| Norne Securities | Hold | Buy | Downgrade | Jan 26, 2015 |
| Natixis | Neutral | Buy | Downgrade | Jan 12, 2015 |
| Handelsbanken | Accumulate | Buy | Maintain | Dec 23, 2014 |
| DNB Markets | Sell | Hold | Downgrade | Dec 18, 2014 |
| Swedbank | Neutral | Buy | Downgrade | Dec 10, 2014 |
| Longbow Research | Buy | Neutral | Upgrade | Oct 4, 2013 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 5, 2013 |
| ABG Sundal Collier | Sell | Hold | Downgrade | Jan 31, 2013 |
| RS Platou Markets | Buy | Neutral | Upgrade | Jan 16, 2013 |
| Topeka Capital | Hold | Buy | Downgrade | Oct 26, 2012 |
| Topeka | Hold | Buy | Downgrade | Oct 26, 2012 |
| Fondsfinans | Neutral | Buy | Downgrade | Apr 16, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $295.92. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Susquehanna | Analyst unavailable | $355 | $281.97 | +20.0% | Oct 20, 2026 |
| Wells Fargo | Analyst unavailable | $358 | $282.26 | +21.0% | Oct 12, 2026 |
| Jefferies | David Katz | $330 | $282.36 | +11.5% | Oct 8, 2026 |
| Barclays | Brandt Montour | $337 | $288.85 | +13.9% | Oct 7, 2026 |
| Deutsche Bank | Analyst unavailable | $299 | $242.7 | +1.0% | Sep 28, 2026 |
| Truist Financial | Patrick Scholes | $298 | $234.64 | +0.7% | Sep 24, 2026 |
| UBS | Robin Farley | $367 | $322.94 | +24.0% | Aug 3, 2026 |
| Morgan Stanley | Analyst unavailable | $300 | $323.58 | +1.4% | Jul 30, 2026 |
| Susquehanna | Christopher Stathoulopoulos | $372 | $322.5 | +25.7% | Jul 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $415 | $322.5 | +40.2% | Jul 29, 2026 |
| Wells Fargo | Trey Bowers | $388 | $322.5 | +31.1% | Jul 29, 2026 |
| BMO Capital | Tristan Thomas-Martin | $370 | $282.26 | +25.0% | Jul 7, 2026 |
| Wells Fargo | Analyst unavailable | $361 | $312.51 | +22.0% | Jun 22, 2026 |
| Loop Capital Markets | Analyst unavailable | $304 | $284.63 | +2.7% | Jun 1, 2026 |
| Morgan Stanley | Analyst unavailable | $280 | $256.1 | -5.4% | May 26, 2026 |
| Truist Financial | Analyst unavailable | $297 | $260.32 | +0.4% | May 22, 2026 |
| UBS | Robin Farley | $309 | $267.71 | +4.4% | May 14, 2026 |
| Mizuho Securities | Analyst unavailable | $380 | $266.14 | +28.4% | May 1, 2026 |
| Deutsche Bank | Analyst unavailable | $296 | $263.76 | +0.0% | May 1, 2026 |
| Stifel Nicolaus | Analyst unavailable | $410 | $263.76 | +38.6% | May 1, 2026 |
| Wells Fargo | Analyst unavailable | $360 | $263.76 | +21.7% | May 1, 2026 |
| Barclays | Brandt Montour | $340 | $263.76 | +14.9% | May 1, 2026 |
| Wells Fargo | Trey Bowers | $349 | $281.53 | +17.9% | Apr 15, 2026 |
| UBS | Analyst unavailable | $321 | $282.41 | +8.5% | Apr 14, 2026 |
| Barclays | Analyst unavailable | $351 | $276.31 | +18.6% | Apr 10, 2026 |
| Morgan Stanley | Analyst unavailable | $310 | $275.89 | +4.8% | Apr 9, 2026 |
| Mizuho Securities | Analyst unavailable | $377 | $279.26 | +27.4% | Apr 8, 2026 |
| Tigress Financial | Analyst unavailable | $425 | $344.95 | +43.6% | Feb 6, 2026 |
| Morgan Stanley | Analyst unavailable | $330 | $339.27 | +11.5% | Feb 3, 2026 |
| Wells Fargo | Trey Bowers | $383 | $324.65 | +29.4% | Feb 1, 2026 |
| Stifel Nicolaus | Steven Wieczynski | $420 | $345.98 | +41.9% | Jan 30, 2026 |
| Mizuho Securities | Analyst unavailable | $379 | $345.98 | +28.1% | Jan 30, 2026 |
| Bernstein | Richard Clarke | $380 | $345.98 | +28.4% | Jan 30, 2026 |
| Goldman Sachs | Analyst unavailable | $370 | $345.98 | +25.0% | Jan 30, 2026 |
| Jefferies | David Katz | $334 | $345.98 | +12.9% | Jan 30, 2026 |
| Barclays | Brandt Montour | $361 | $345.98 | +22.0% | Jan 30, 2026 |
| Goldman Sachs | Analyst unavailable | $310 | $285.55 | +4.8% | Jan 23, 2026 |
| Truist Financial | Patrick Scholes | $318 | $277.77 | +7.5% | Jan 22, 2026 |
| Mizuho Securities | Analyst unavailable | $381 | $275.45 | +28.8% | Jan 22, 2026 |
| Stifel Nicolaus | Analyst unavailable | $380 | $276.01 | +28.4% | Jan 20, 2026 |
| Wells Fargo | Trey Bowers | $373 | $301.13 | +26.0% | Jan 13, 2026 |
| Barclays | Brandt Montour | $324 | $281.51 | +9.5% | Dec 17, 2025 |
| Jefferies | David Katz | $275 | $278.7 | -7.1% | Dec 15, 2025 |
| Goldman Sachs | Analyst unavailable | $275 | $252.41 | -7.1% | Dec 9, 2025 |
| Truist Financial | Patrick Scholes | $321 | $266.6 | +8.5% | Dec 2, 2025 |
| RBC Capital | Analyst unavailable | $360 | $285.15 | +21.7% | Oct 31, 2025 |
| Susquehanna | Christopher Stathoulopoulos | $350 | $286.14 | +18.3% | Oct 30, 2025 |
| Stifel Nicolaus | Steven Wieczynski | $400 | $286.92 | +35.2% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $342 | $292.95 | +15.6% | Oct 29, 2025 |
| Mizuho Securities | Ben Chaiken | $362 | $300.31 | +22.3% | Oct 20, 2025 |
| Truist Financial | Analyst unavailable | $333 | $327.82 | +12.5% | Sep 19, 2025 |
| UBS | Robin Farley | $353 | $305.72 | +19.3% | Aug 8, 2025 |
| Truist Financial | Patrick Scholes | $337 | $333.96 | +13.9% | Jul 30, 2025 |
| Susquehanna | Analyst unavailable | $385 | $331.15 | +30.1% | Jul 30, 2025 |
| UBS | Robin Farley | $311 | $249.2 | +5.1% | May 20, 2025 |
| BNP Paribas | Analyst unavailable | $262 | $217.24 | -11.5% | Mar 27, 2025 |
| Loop Capital Markets | Laura Champine | $250 | $263.59 | -15.5% | Feb 4, 2025 |
| Argus Research | John Staszak | $280 | $228.92 | -5.4% | Jan 3, 2025 |
| Truist Financial | Patrick Scholes | $272 | $246.16 | -8.1% | Dec 2, 2024 |
| Macquarie | Paul Golding | $250 | $208.36 | -15.5% | Oct 30, 2024 |
| Goldman Sachs | Lizzie Dove | $245 | $208.36 | -17.2% | Oct 30, 2024 |
| Mizuho Securities | Ben Chaiken | $224 | $207.57 | -24.3% | Oct 30, 2024 |
| Barclays | Brandt Montour | $245 | $210.1 | -17.2% | Oct 30, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $250 | $210.1 | -15.5% | Oct 29, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $230 | $195.69 | -22.3% | Oct 11, 2024 |
| Citigroup | James Hardiman | $253 | $183.39 | -14.5% | Oct 9, 2024 |
| Truist Financial | Patrick Scholes | $204 | $177.41 | -31.1% | Sep 26, 2024 |
| Argus Research | John Staszak | $172 | $150.13 | -41.9% | May 29, 2024 |
| Wells Fargo | Daniel Politzer | $165 | $142.86 | -44.2% | May 17, 2024 |
| Macquarie | Paul Golding | $165 | $137.47 | -44.2% | Apr 25, 2024 |
| Mizuho Securities | Ben Chaiken | $164 | $126.6 | -44.6% | Apr 17, 2024 |
| Barclays | Brandt Montour | $154 | $130.9 | -48.0% | Apr 11, 2024 |
| Goldman Sachs | Lizzie Dove | $162 | $132.11 | -45.3% | Mar 13, 2024 |
| Credit Suisse | Benjamin Chaiken | $104 | $75.61 | -64.9% | May 5, 2023 |
| Susquehanna | Analyst unavailable | $85 | $74.79 | -71.3% | Feb 8, 2023 |
| Deutsche Bank | Analyst unavailable | $65 | $74.01 | -78.0% | Feb 8, 2023 |
| Morgan Stanley | Analyst unavailable | $50 | $58.42 | -83.1% | Jan 10, 2023 |
| UBS | Analyst unavailable | $82 | $56.77 | -72.3% | Jan 9, 2023 |
| J.P. Morgan | Analyst unavailable | $47 | $56.78 | -84.1% | Dec 6, 2022 |
| Truist Financial | Analyst unavailable | $62 | $58.76 | -79.0% | Nov 22, 2022 |
| Wells Fargo | Analyst unavailable | $67 | $57.46 | -77.4% | Nov 21, 2022 |
| UBS | Analyst unavailable | $76 | $58.07 | -74.3% | Nov 14, 2022 |
| Truist Financial | Analyst unavailable | $58 | $50.68 | -80.4% | Sep 20, 2022 |
| Stifel Nicolaus | Analyst unavailable | $70 | $51.87 | -76.3% | Sep 19, 2022 |
| Barclays | Brandt Montour | $61 | $50.44 | -79.4% | Sep 19, 2022 |
| Morgan Stanley | Analyst unavailable | $40 | $37.4 | -86.5% | Jul 29, 2022 |
| Deutsche Bank | Chris Woronka | $50 | $35.29 | -83.1% | Jul 2, 2022 |
| Barclays | Brandt Montour | $56 | $40.14 | -81.1% | Jun 28, 2022 |
| Morgan Stanley | Analyst unavailable | $54 | $55.89 | -81.8% | Jun 8, 2022 |
| Truist Financial | Patrick Scholes | $65 | $55.41 | -78.0% | May 23, 2022 |
| Goldman Sachs | Analyst unavailable | $75 | $59.94 | -74.7% | May 11, 2022 |
| Morgan Stanley | Analyst unavailable | $59 | $62.52 | -80.1% | May 11, 2022 |
| UBS | Robin Farley | $86 | $60.92 | -70.9% | May 11, 2022 |
| Deutsche Bank | Analyst unavailable | $76 | $69.94 | -74.3% | May 6, 2022 |
| Stifel Nicolaus | Steven Wieczynski | $118 | $76.18 | -60.1% | Mar 19, 2022 |
| J.P. Morgan | Brandt Montour | $111 | $78.1 | -62.5% | Aug 5, 2021 |
| UBS | Robin M. Farley | $118 | $78.46 | -60.1% | May 13, 2021 |
| Goldman Sachs | Stephen Grambling | $95 | $84.69 | -67.9% | Apr 21, 2021 |
Track every rating change on RCL the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRoyal Caribbean Cruises Ltd. is a prominent global operator within the cruise sector. The company manages several well-known cruise lines, such as Royal Caribbean International, Celebrity Cruises, Azamara, and Silversea Cruises. Through these brands, it offers a wide array of voyages that call upon approximately 1,000 different destinations across the globe. As of February 25, 2022, its expansive fleet comprised 61 vessels. Established in 1968, the company's corporate headquarters are situated in Miami, Florida.
Historical context
All RCL earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DECK Deckers Outdoor Corporation | FY2027 Q2 · Calendar Q4 2026 | +13.4% | -0.2% | Deckers raises FY2027 outlook as HOKA and UGG drive growth |
Latest beats and misses
Who reports nextBeat on EPS
- CLSFY2026 Q3 · October 26, 2026+12.6% EPS+12.1% move
- CINFFY2026 Q3 · October 26, 2026+39.5% EPS+2.3% move
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
Missed on EPS
- PSA-PKFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PGFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSAFY2026 Q3 · October 26, 2026-32.1% EPS+1.8% move
- SUIFY2026 Q3 · October 26, 2026-20.0% EPS-4.1% move
- PSA-PIFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PJFY2026 Q3 · October 26, 2026-32.1% EPS— move
Get the RCL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-27T18:04:09.140307+00:00
- FN2 earnings calendar · 2026-10-27T01:23:15.065758+00:00
- Polygon adjusted daily market bars · 2026-10-27T18:20:41.420917+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T18:20:41.418274+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.